About the Next Generation Dx Summit 2026
Welcome to the Next Generation Dx Summit, the premier international nexus for diagnostic advancement, clinical technology innovation, and the evolution of healthcare standards. Hosted by the Cambridge Healthtech Institute (CHI), this milestone event enters its 18th year as the definitive global stage for leaders shaping the future of medical diagnostics.
Our mission is to bridge the gap between breakthrough science and clinical implementation. By bringing together world-class thought leaders, researchers, and industry executives, the Next Generation Dx Summit accelerates the commercialization and adoption of state-of-the-art diagnostic technologies to improve the global standard of care in medicine.
Shaping the Future of Medical Diagnostics
The diagnostic landscape is evolving rapidly. The Next Generation Dx Summit 2026 provides an unparalleled window into the market forecasting, regulatory shifts, and future trends defining the industry.
We serve as an essential accelerator and nexus for professionals seeking comprehensive coverage of the most timely and important topics in the medical and clinical laboratory diagnostic sectors.
Our Core Areas of Diagnostic Specialization & Service
To address the critical challenges and breakthroughs in the field, our comprehensive program focuses on key areas driving clinical innovation:
- Point-of-Care & At-Home Testing: Discover breakthroughs in decentralized healthcare delivery, rapid testing technology, and user-centric diagnostic tools
- Oncology & Early Cancer Detection: Delve into deep-dive sessions on the latest methodologies for Multi-Cancer Early Detection (MCED) and Single-Cancer Early Detection platforms
- Infectious Disease Diagnostics: Stay ahead of emerging pathogens with next-generation molecular pathology and surveillance innovations
- Reimbursement & Market Access: Navigate commercialization hurdles, evidence-generation requirements, and multi-payer coverage strategies
- Regulatory Affairs & Policy: Understand the shifting compliance frameworks governing companion diagnostics, laboratory-developed tests (LDTs), and global approvals
- Companion Diagnostics (CDx): Explore targeted therapies and personalized medicine approaches driven by innovative biomarker discovery
Join the Nexus of Diagnostic Innovation
Whether you are looking to secure incomparable networking opportunities with industry leaders, benchmark your diagnostic pipeline against state-of-the-art technologies, or gain insights into the future of reimbursement and regulation, this is your must-attend event.
Register for the Next Generation Dx Summit 2026 Today